Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience.

导出原文传递

翻译打印收藏纠错

第一作者： Yair,Herishanu

第一单位： Department of Hematology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.;Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

作者： Yair,Herishanu ^[1] ; Tamar,Tadmor ^[2] ; Andrei,Braester ^[3] ; Osnat,Bairey ^[4] ; Ariel,Aviv ^[5] ; Naomi,Rahimi-Levene ^[6] ; Riva,Fineman ^[7] ; Itai,Levi ^[8] ; Mona,Yuklea ^[9] ; Rosa,Ruchlemer ^[10] ; Lev,Shvidel ^[11] ; Aaron,Polliack ^[12]

作者单位： Department of Hematology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.;Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. ^[1] Hematology Unit, Bnai-Zion Medical Center, Haifa, Israel. ^[2] Department of Hematology, Galilee Medical Center and Faculty of Medicine in Galilee, Nahariya, Israel. ^[3] Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.;Department of Hematology, Rabin Medical Center, Petah Tikva, Israel. ^[4] Department of Hematology, Emek Medical Center, Afula, Israel. ^[5] Department of Hematology, Assaf Harofe Medical Center, Zerifin, Israel. ^[6] Department of Hematology, Rambam Medical Center, Haifa, Israel. ^[7] Department of Hematology, Soroka Medical Center, Beer Sheba and Ben-Gurion University, Beer Sheba, Israel. ^[8] Department of Hematology, Sapir Medical Center, Kfar Saba, Israel. ^[9] Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel. ^[10] Department of Hematology, Kaplan Medical Center, Rehovot, Israel. ^[11] Department of Hematology, Hadassah University Hospital and Hebrew University Medical School, Jerusalem, Israel. ^[12]

关键词 CLL LD-FCR chemo-immunotherapy elderly fludarabine rituximab